Blockchain Registration Transaction Record
TransCode Therapeutics Advances RNA-Based Cancer Therapeutic in Phase 1a Trial
TransCode Therapeutics announces progress in Phase 1a trial for RNA-based cancer therapeutic TTX-MC138, with expanded enrollment and positive safety profile. Promising results show target engagement and potential for treating metastatic tumors.

This news highlights the progress of TransCode Therapeutics in developing innovative RNA therapeutics for treating metastatic cancer, demonstrating promising results in its Phase 1a trial. The approval of expanded enrollment and positive safety profile signify a step forward in the fight against cancer, offering hope for patients with metastatic tumors.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xb392aa531e34e0433639375b49fff8e5eebb8d26c8f3db77e96ae795f5d6bf91 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | cornCOkY-4115419145895524b63c7f139f7e77af |